WealthBridge Capital Management’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

WealthBridge Capital Management’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$438K	Buy	+1,766	New	+$380K	0.09%	156
2019 Q2	–	Sell	-355	Closed	-$48K	–	351
2019 Q1	$48K	Buy	355 +20	+6%	+$2.88K	0.03%	290
2018 Q4	$42K	Buy	+335	New	+$45.8K	0.03%	268

Other funds holding FBT

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Bessemer Group Woodbridge, New Jersey $72.7B AUM 39.36% 1-Year Est. Return

BFG

Berger Financial Group Plymouth, Minnesota $1.96B AUM 20.58% 1-Year Est. Return

WealthBridge Capital Management's FBT Position: Q2 2026 in Review

WealthBridge Capital Management opened a new position in First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q2 2026: 1,766 shares worth $438K. The stake represents 0.09% of the portfolio and ranks #156 among its holdings. This is a return to the name: WealthBridge Capital Management previously reported a position in FBT as recently as Q1 2019.

WealthBridge Capital Management first reported a position in FBT in Q4 2018 and has held it in 3 quarters since. 340 funds tracked by Wall St. Rank hold FBT as of Q2 2026.

WealthBridge Capital Management held 1,766 shares of First Trust NYSE Arca Biotechnology Index Fund worth $438K as of Q2 2026.
First Trust NYSE Arca Biotechnology Index Fund was a new WealthBridge Capital Management position in Q2 2026.
First Trust NYSE Arca Biotechnology Index Fund made up 0.09% of WealthBridge Capital Management's portfolio in Q2 2026, its #156 holding.
WealthBridge Capital Management first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q4 2018 and has held it in 3 quarters since.
340 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2026.

Based on WealthBridge Capital Management's 13F filing for Q2 2026, filed 24 Jul 2026.